Comparison of iron kinetics maintenance from Darbepoetin for hemodialysis patients to Epoetin beta pegol administration switching administration and Epoetin beta pegol twice a month as an index hepcidin 25 -ERI (prospective observational study)
- Conditions
- renal anemia
- Registration Number
- JPRN-jRCT1090220252
- Lead Sponsor
- shogo kimura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
A common selection criteria)
Patients - three times a week hemodialysis have received more than one year
Patients obvious iron deficiency is not observed in-the past three months
- 20 years of age or older patients
Patients who obtained the consent, with respect to the present study
(A group)
DA was administered once a week Hb is 7.1 - 9.9g / dL and the effect inadequate for switching to CERA
Patients were example
Patient - DA dose per week of 10 - 60
(B group)
Patients receiving CERA - twice a monthPatients and one month CERA dose per month of 50 -200
Patients - Hb concentration of the past three months has remained at 10 - 12g / d
Patient management is insufficient -Hb concentration
(Hb patients <7g / dL or Hb,> 13g / dL has been confirmed)
Hypertensive patients poorly controlled with oral medicine,
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hb,Frt,TSAT,Hep,MCV,at the start of ERI value at the end of ERI value
- Secondary Outcome Measures
Name Time Method Target Hb retention rate